REMSleep Holdings, Inc. announced that testing for ISO 18562-4:2017 has been completed. Company is actively compiling all necessary documentation to submit the analysis to the FDA to proceed with current 510k application. Further updates will be forthcoming.

Company look forward to concluding 510k application with the FDA very soon.